BMP4 and neoplasm: Liposomal clodronate treatment impairs BMP4 induction, delays development of stress BFU-E of spleen and severely reduces peripheral erythroid in tumor-bearing mice, consistent with the requirement of macrophages to mount BMP4-mediated stress erythropoiesis.